To continue reading this content, please enable JavaScript in your browser settings and refresh this page. San Francisco, with its blend of diversity and innovation ...
EUDA Health Holdings Limited, a Singapore-based health technology company, has announced preliminary discussions with Guangdong Cell Biotech Co. Ltd., a leader in stem cell therapies and regenerative ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
EUDA Health (EUDA) announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. to form a joint venture. Guangdong Cell Biotech develops autologous cell treatments and ...
Biotechnology has the potential to help mitigate threats to North American forests from insect pests and pathogens through the introduction of pest-resistant traits. However, it also presents some ...
One biotech leader is sounding the alarm on a dire problem faced by the health care system, warning that it could imminently "bankrupt" the industry. "We need to do something about Alzheimer's… It's ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Amid growing market volatility, regulatory uncertainty and heightened scrutiny by the federal government and general public, the role of biotech communicators has never been more critical — or more ...
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed ...
Massachusetts is a hub for biotech: According to the 2024 MassBio industry snapshot, biopharma accounted for more than 15% of job growth in the entire state last year. This month, we’re hearing from ...
The European Commission has published an analysis detailing the benefits of enacting the European Biotech Act, which was ...
LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results